Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Dept. |
RCV002281190 | SCV002102517 | pathogenic | Mucopolysaccharidosis, type 10 | 2022-03-07 | no assertion criteria provided | clinical testing | The Tyr417* variant introduces a premature termination codon and targets ARSK-mRNA for nonsense-mediated decay. LoF-variants in ARSK are known to be pathogenic (PMID:34916232). The variant is absent from large population studies (gnomAD). PVS1, PM2 |